ArticleFrontiers in neuroscience2026
Machine learning-based morphological brain analysis in schizophrenia and unaffected siblings: a multisite study of potential risk markers.
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and hypothesis: Assessing schizophrenia risk factors is crucial for developing early preventive interventions. We hypothesized that unaffected siblings, who share high genetic risk, exhibit neuroanatomical signatures similar to affected patients, potentially reflecting early pathogenic processes. Study design: To overcome single-center limitations, we analyzed 1,018 participants from five independent, public databases. Brain MRIs were standardized via voxel-based morphometry, and covariate-adjusted z-scores were calculated for regional volumes. An ensemble support vector machine (SVM) approach, incorporating multiple models to ensure robustness, was employed to extract a multidimensional brain signature, from which a schizophrenia-like score (SPS) was derived. Results: The ensemble SVM achieved high classification performance (AUC = 0.99861). Across all databases, patients exhibited consistent volume reductions in frontal, temporal, insular, and thalamic regions, alongside globus pallidus enlargement. Notably, unaffected siblings were 3.8 times more likely to show brain morphological similarities to patients than were healthy controls. Furthermore, we identified a novel imaging phenotype in siblings: increased ventral striatal volume, which positively correlated with the SPS. This feature, absent in established schizophrenia, suggests a potential compensatory mechanism or a transient developmental marker of risk. Conclusion: Applying machine learning to large-scale, multi-site neuroimaging data effectively identifies structural endophenotypes. Our findings highlight unique structural characteristics, specifically the enlarged ventral striatum, as a critical biological metric for identifying high-risk individuals before clinical onset.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.